Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey L Allen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Child Development|December 4, 2012
A U-shaped relation between sitting ability and upright face processing in infantsCara H Cashon, Oh-Ryeong Ha, Casey L Allen, et al.
Regulatory Toxicology and Pharmacology : RTP|July 28, 2015
Safety assessment for ethanol-based topical antiseptic use by health care workers: Evaluation of developmental toxicity potentialAndrew Maier, Jerald L Ovesen, Casey L Allen, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999Charles W DeBrosse, Margaret H Collins, Bridget K Buckmeier Butz, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck CancerOlga Zamulko, Sam Nusbaum, Andrew Osterburg, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell CarcinomaTrisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Child Development|December 4, 2012
A U-shaped relation between sitting ability and upright face processing in infantsCara H Cashon, Oh-Ryeong Ha, Casey L Allen, et al.
Regulatory Toxicology and Pharmacology : RTP|July 28, 2015
Safety assessment for ethanol-based topical antiseptic use by health care workers: Evaluation of developmental toxicity potentialAndrew Maier, Jerald L Ovesen, Casey L Allen, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999Charles W DeBrosse, Margaret H Collins, Bridget K Buckmeier Butz, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck CancerOlga Zamulko, Sam Nusbaum, Andrew Osterburg, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell CarcinomaTrisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Pageof 1